AML
Continuous Temperature Monitoring Could Detect Febrile Neutropenia
Remote temperature monitoring devices may enable early detection of febrile neutropenia in adults with AML who have ...
MAY 21, 2024
New Treatment OK’d for Newly Diagnosed IDH1-Mutant AML
The FDA approved the combination of ivosidenib (Tibsovo, Servier) plus azacitidine for adults aged 75 years and ...
MAY 27, 2022
Onureg, Oral Formulation of Azacitidine, Approved for AML
The FDA granted approval to azacitidine tablets (Onureg, Celgene) for treatment of patients with acute myeloid ...
SEPTEMBER 4, 2020
Targeted Agents Make Their Mark in AML
Over the past two years, eight novel targeted agents have been added to the treatment arsenal for acute myeloid ...
AUGUST 15, 2019
FDA Approves Vyxeos for 2 Types of AML
The FDA approved Vyxeos, Jazz Pharmaceuticals)to treat adults with two types of acute myeloid leukemia (AML): newly ...
AUGUST 4, 2017
FDA Approves Idhifa and RealTime IDH2 Assay for Relapsed or Refractory AML
Celgene's Idhifa was approved to treat adult patients with relapsed or refractory AML who have a specific genetic ...
AUGUST 2, 2017
